iMDK|cas:881970-80-5|西域试剂

iMDK,99.34%

产品编号：Bellancom-110171| CAS NO：881970-80-5| 分子式：C₂₁H₁₃FN₂O₂S| 分子量：376.40

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-110171	￥1600.00	杭州北京（现货）
Bellancom-110171	￥2500.00	杭州北京（现货）
Bellancom-110171	￥5500.00	杭州北京（现货）
Bellancom-110171	￥9500.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

iMDK

产品介绍

iMDK 是一种有效的 PI3K 抑制剂，可抑制生长因子 MDK（也称为中期因子或 MK）。iMDK 与 MEK 抑制剂协同抑制非小细胞肺癌 (NSCLC)，而不会伤害正常细胞和小鼠。

生物活性

iMDK is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice.

体外研究

iMDK (50–500 nM) suppressed AKT phosphorylation in a dose-dependent manner in H441 lung adenocarcinoma cells after treatment for 72 h. In contrast, iMDK robustly increases p-ERK.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line:	H441 (lung adenocarcinoma; KRAS^G12V), H2009 (non-small cell carcinoma; KRAS^G12A), A549 (lung carcinoma; KRAS^G12S) and H520 (lung squamous cell carcinoma; KRAS^WT)
Concentration:	iMDK (2.5 μM) and PD0325901 (0.5 μM) for H441 and H2009 cells iMDK (0.125 μM) and PD0325901 (0.25 μM) for H520 cells iMDK (0.25 μM) and PD0325901 (0.125 μM) for A549 cells
Incubation Time:	72 hours
Result:	iMDK alone did not inhibit cell viability of A549 cells, the combinatorial treatment of iMDK with PD0325901 significantly inhibited that of A549 cells compared to the single treatment of PD0325901.

Western Blot Analysis

Cell Line:	H441 lung adenocarcinoma cells
Concentration:	0-500 nM
Incubation Time:	72 hours
Result:	Suppressed AKT phosphorylation in a dose-dependent manner. ERK1/2 phosphorylation was increased.

体内研究
(In Vivo)

The combination treatment of iMDK ( (9 mg/kg/day; intraperitoneally injected with 100 μl) and PD0325901 (5 mg/kg; orally administered) effectively reduced lung tumor growth in a xenograft mouse model.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	female BALB/c nude mice (6 week old) bearing H441 human lung cancer xenografts
Dosage:	iMDK (9 mg/kg) and PD0325901 (5 mg/kg)
Administration:	Intraperitoneally injected with 100 μL iMDK everyday and/or orally administered PD0325901 five times per week (on days 1, 2, 3, 4, 5, 7, 8, 9, 10, 11)
Result:	Reduced significantly volume of the tumors derived from H441 lung adenocarcinoma cells after the combination treatment with iMDK and PD0325901 compared to that of single compound in a xenograft mouse model.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	female BALB/c nude mice (6 week old) bearing H441 human lung cancer xenografts
Dosage:	iMDK (9 mg/kg) and PD0325901 (5 mg/kg)
Administration:	Intraperitoneally injected with 100 μL iMDK everyday and/or orally administered PD0325901 five times per week (on days 1, 2, 3, 4, 5, 7, 8, 9, 10, 11)
Result:	Reduced significantly volume of the tumors derived from H441 lung adenocarcinoma cells after the combination treatment with iMDK and PD0325901 compared to that of single compound in a xenograft mouse model.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	female BALB/c nude mice (6 week old) bearing H441 human lung cancer xenografts
Dosage:	iMDK (9 mg/kg) and PD0325901 (5 mg/kg)
Administration:	Intraperitoneally injected with 100 μL iMDK everyday and/or orally administered PD0325901 five times per week (on days 1, 2, 3, 4, 5, 7, 8, 9, 10, 11)
Result:	Reduced significantly volume of the tumors derived from H441 lung adenocarcinoma cells after the combination treatment with iMDK and PD0325901 compared to that of single compound in a xenograft mouse model.

性状

Solid

溶解性数据

In Vitro:

DMSO : 3.33 mg/mL (8.85 mM; ultrasonic and warming and heat to 60°C)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.6567 mL	13.2837 mL	26.5675 mL
5 mM	0.5313 mL	2.6567 mL	5.3135 mL
10 mM	---	---	---

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式